Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults
Jolien Schaeverbeke, Silvy Gabel, Karen Meersmans, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Physical activity as a protective factor for dementia and Alzheimer’s disease: systematic review, meta-analysis and quality assessment of cohort and case–control studies
Paula Iso‐Markku, Urho M. Kujala, Keegan Knittle, et al.
British Journal of Sports Medicine (2022) Vol. 56, Iss. 12, pp. 701-709
Open Access | Times Cited: 219
Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons
Sebastiaan Moonen, Marta J. Koper, Evelien Van Schoor, et al.
Acta Neuropathologica (2022) Vol. 145, Iss. 2, pp. 175-195
Open Access | Times Cited: 119
Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer’s disease
Disha Shah, Willy Gsell, Jérôme Wahis, et al.
Cell Reports (2022) Vol. 40, Iss. 8, pp. 111280-111280
Open Access | Times Cited: 81
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Diagnostic accuracy of the Montreal Cognitive Assessment in screening for cognitive impairment in initially hospitalized COVID-19 patients: Findings from the prospective multicenter NeNeSCo study
Simona Klinkhammer, Esmée Verwijk, Gert J. Geurtsen, et al.
Journal of the International Neuropsychological Society (2025), pp. 1-8
Open Access
Natural language processing‐based classification of early Alzheimer's disease from connected speech
Helena Balabin, Bastiaan Tamm, Laure Spruyt, et al.
Alzheimer s & Dementia (2025)
Open Access
Linking higher amyloid beta 1‐38 (Aβ(1‐38)) levels to reduced Alzheimer's disease progression risk
Luisa‐Sophie Schneider, Silka Dawn Freiesleben, Gerard van Breukelen, et al.
Alzheimer s & Dementia (2025)
Open Access
Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
Duygu Tosun, Zeynep Demir, Dallas P. Veitch, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 7, pp. 1370-1382
Open Access | Times Cited: 29
Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease
Steffi De Meyer, Jeroen Vanbrabant, Jolien Schaeverbeke, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 5, pp. 734-746
Open Access | Times Cited: 19
Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults
Emma S. Luckett, Magdalena Zielonka, Amine Kordjani, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid-PET
Steffi De Meyer, Jolien Schaeverbeke, Emma S. Luckett, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 4
It's all about cognitive trajectory: Accuracy of the cognitive charts–MoCA in normal aging, MCI, and dementia
Patrick J. Bernier, Christian Gourdeau, Pierre‐Hugues Carmichael, et al.
Journal of the American Geriatrics Society (2022) Vol. 71, Iss. 1, pp. 214-220
Open Access | Times Cited: 17
The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact
Lyduine E. Collij, Gill Farrar, David Vállez García, et al.
Frontiers in Neurology (2023) Vol. 13
Open Access | Times Cited: 10
Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes
Steffi De Meyer, Elena R. Blujdea, Jolien Schaeverbeke, et al.
Brain (2023) Vol. 147, Iss. 3, pp. 936-948
Open Access | Times Cited: 10
Association of Alzheimer’s disease polygenic risk scores with amyloid accumulation in cognitively intact older adults
Emma S. Luckett, Yasmina Abakkouy, Mariska Reinartz, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Longitudinal stability in working memory and frontal activity in relation to general brain maintenance
Lars Nyberg, Nina Karalija, Goran Papenberg, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Lack of cognitive impairment in long-term survivors of colorectal cancer
Janette Vardy, Gregory R. Pond, Lucette A. Cysique, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 7, pp. 6123-6133
Open Access | Times Cited: 9
Current Potential for Clinical Optimization of Social Cognition Assessment for Frontotemporal Dementia and Primary Psychiatric Disorders
Jan Van den Stock, Maxime Bertoux, Janine Diehl‐Schmid, et al.
Neuropsychology Review (2022) Vol. 33, Iss. 2, pp. 544-550
Open Access | Times Cited: 9
Changes in the language system as amyloid-β accumulates
Mariska Reinartz, Silvy Gabel, Jolien Schaeverbeke, et al.
Brain (2021) Vol. 144, Iss. 12, pp. 3756-3768
Open Access | Times Cited: 11
Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach
Yulin Dai, Yu‐Chun Hsu, Brisa S. Fernandes, et al.
Journal of Alzheimer s Disease (2024) Vol. 97, Iss. 4, pp. 1807-1827
Open Access | Times Cited: 1
Impact of care–recipient relationship type on quality of life in caregivers of older adults with dementia over time
Aiping Lai Kin, Lauren E Griffith, Ayse Kuspinar, et al.
Age and Ageing (2024) Vol. 53, Iss. 6
Open Access | Times Cited: 1
Characterizing the clinical heterogeneity of early symptomatic Alzheimer’s disease: a data-driven machine learning approach
Xiwu Wang, Teng Ye, Deguo Jiang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 1
Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth
Mariska Reinartz, Emma S. Luckett, Jolien Schaeverbeke, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 11, pp. 3772-3786
Open Access | Times Cited: 7
Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
Emma S. Luckett, Jolien Schaeverbeke, Steffi De Meyer, et al.
NeuroImage Clinical (2023) Vol. 37, pp. 103321-103321
Open Access | Times Cited: 3
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study
Ilse Bader, Ilona Bader, Isadora Lopes Alves, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top